EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha...
32
EXHIBIT 38
Transcript of EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha...
![Page 1: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/1.jpg)
EXHIBIT 38
![Page 2: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/2.jpg)
![Page 3: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/3.jpg)
![Page 4: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/4.jpg)
![Page 5: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/5.jpg)
![Page 6: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/6.jpg)
![Page 7: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/7.jpg)
![Page 8: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/8.jpg)
![Page 9: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/9.jpg)
![Page 10: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/10.jpg)
![Page 11: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/11.jpg)
![Page 12: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/12.jpg)
![Page 13: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/13.jpg)
![Page 14: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/14.jpg)
![Page 15: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/15.jpg)
![Page 16: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/16.jpg)
![Page 17: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/17.jpg)
![Page 18: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/18.jpg)
![Page 19: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/19.jpg)
![Page 20: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/20.jpg)
![Page 21: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/21.jpg)
![Page 22: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/22.jpg)
![Page 23: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/23.jpg)
![Page 24: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/24.jpg)
![Page 25: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/25.jpg)
![Page 26: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/26.jpg)
![Page 27: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/27.jpg)
![Page 28: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/28.jpg)
![Page 29: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/29.jpg)
![Page 30: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/30.jpg)
![Page 31: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/31.jpg)
![Page 32: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did](https://reader030.fdocuments.us/reader030/viewer/2022040216/5f0c7edf7e708231d435b0a1/html5/thumbnails/32.jpg)